The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Potential pathogenesis of ageusia and anosmia in COVID‐19 patients
Open accessAbstract
To the Editor, The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Europe and America is enabling researchers to acquire a large amount of clinical data. Interestingly, some of these findings differ significantly from those reported in Chinese case studies. In particular, the presence of taste and smell alterations seems to be a frequent clinical feature of the coronavirus disease 19 (COVID-19), with a frequency ranging from 19.4% to 88% of patients.1-4 The exact pathogenesis of these chemosensitive disorders has not yet been clarified. At the same time, the comprehension of these mechanisms could be fruitful to understand the way in which the virus spreads through the organism. We report our survey of the literature up to April 14, 2020, analyzing the possible causes of these chemosensory alterations, which may be useful as a starting point for specific future studies. There are no studies in the literature regarding the possible relationship between coronavirus and the development of taste disorders. Angiotensin-converting enzyme 2 (ACE2) has been identified as the cellular receptor for SARS-CoV-2.5 ACE2 receptors are expressed diffusely on the mucous membrane of the entire oral cavity, particularly on the tongue.6 The role of ACE2 in modulating taste perception has been highlighted in many studies analyzing the chemosensitive side effects of ACE2 inhibitors and angiotensin II blockers.7, 8 The mechanism by which ACE2 inhibitors cause taste disturbance is unclear but does not appear to be related to any alteration in serum7, 8 and saliva7 zinc levels. Presumably, these drugs inactivate the G-protein-coupled proteins and sodium-ion channels present in the taste receptors.5 The taste disturbance generally regresses after suspension of treatment.8 Moreover, the Middle East Respiratory Syndrome (MERS) coronavirus may bind to the sialic acid receptors,9 an ability that has also recently been described for SARS-CoV-2.10 Sialic acid is a fundamental component of the salivary mucin, and it protects the glycoproteins that convey gustatory molecules inside the taste pores from premature enzymatic degradation.11 A reduction of sialic acid in the saliva is associated with an increase in the gustatory threshold.12 In such a way, SARS-CoV-2 could therefore occupy the binding sites of sialic acid on the taste buds, accelerating the degradation of the gustatory particles. Another possibility is that the ability to perceive flavors in these patients is adversely affected by the concomitant presence of olfactory disturbances, due to the intimate functional correlation between these 2 chemosensory systems.13 However, in the first published case series, taste dysfunctions were always more frequent then olfactory disturbances, presenting alone in 10.2% to 22.5% of patients.2-4 This finding could lead to the hypothesis that the correlation between the 2 dysfunctions is not so close and that there are other factors behind the gustatory disorders in these patients. ACE2 is expressed on the nasal mucosa, where it participates in respiratory inflammatory diseases by regulating the levels of inflammatory peptides, such as bradykinin.14 However, in COVID-19 patients such an important inflammatory component does not seem to be present and the alteration of the sense of smell is generally not accompanied by rhinitis symptoms.1, 3 Therefore, 1 hypothesis could be that the alterations are due to damage caused by the virus to the olfactory pathways. Anosmia has already been described in common coronavirus infections.15, 16 In 2006, Hwang17 described a case of anosmia that persisted for 2 years after SARS had been contracted. In 2001, Schwob et al.18 and Youngentob et al.19 evaluated the anatomopathological and functional consequences of olfactory bulb line variant mouse hepatitis virus intranasal inoculation in murine models. The histopathological analysis of the anosmic mice revealed a minimal destruction of the olfactory epithelium, which was nonetheless abnormal due to the predominance of immature neurons, an indication of an accelerated cell turnover.18, 19 The reduction in the neuronal lifespan in the epithelium is most likely to be the consequence of a decrease in the trophic support supplied by the bulb to the sensory neurons, caused by the loss of mitral cells and the absence of dendrites of the surviving mitral and tufted cells from the glomerular layer.18, 19 Accordingly, the virus may carry out its damage at the level of the olfactory bulb rather than the epithelium. However, the coronavirus used in these studies has been laboratory-modified to specifically target the olfactory bulb. This is not necessarily the same for SARS-CoV-2, which we know has different organ targets. Nevertheless, these authors, while clarifying the target of the virus, did not provide clear indications on the exact pathogenesis of neuronal death. In 2008, Netland et al.20 reported the effects of the SARS-CoV infectio
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0074-x · Cited by 2,838
Lechien, J. R., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S. D., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., et al. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-05965-1 · Cited by 2,668
Giacomelli, A., Pezzati, L., Conti, F., Bernacchia, D., Siano, M., Oreni, L., Rusconi, S., Gervasoni, C., Ridolfo, A. L., Rizzardini, G., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa330 · Cited by 1,326
Netland, J., Meyerholz, D. K., Moore, S., Cassell, M., & Perlman, S. (2008) · Journal of Virology · doi:10.1128/jvi.00737-08 · Cited by 1,293
Brann, D. H., Tsukahara, T., Weinreb, C., Lipovsek, M., Van den Berge, K., Gong, B., Chance, R., Macaulay, I. C., Chou, H.-J., Fletcher, R. B., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc5801 · Cited by 1,198
Yan, C. H., Faraji, F., Prajapati, D. P., Boone, C. E., & DeConde, A. S. (2020) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22579 · Cited by 754
Odor/taste integration and the perception of flavor
Small, D. M., & Prescott, J. (2005) · Experimental Brain Research · doi:10.1007/s00221-005-2376-9 · Cited by 712
Anosmia and Ageusia: Common Findings in COVID‐19 Patients
Vaira, L. A., Salzano, G., Deiana, G., & De Riu, G. (2020) · The Laryngoscope · doi:10.1002/lary.28692 · Cited by 661
Self-citation
Cited by
The SARS-CoV-2 as an instrumental trigger of autoimmunity
Dotan, A., Muller, S., Kanduc, D., David, P., Halpert, G., & Shoenfeld, Y. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102792 · Cited by 494
Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection
Butowt, R., & von Bartheld, C. S. (2021) · The Neuroscientist · doi:10.1177/1073858420956905 · Cited by 345
The neurological manifestations of COVID-19: a review article
Niazkar, H. R., Zibaee, B., Nasimi, A., & Bahri, N. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04486-3 · Cited by 284
Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
Salamanna, F., Maglio, M., Landini, M. P., & Fini, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.594495 · Cited by 281
Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression
Bohn, M. K., Hall, A., Sepiashvili, L., Jung, B., Steele, S., & Adeli, K. (2020) · Physiology · doi:10.1152/physiol.00019.2020 · Cited by 258
Metadata
- Authors
- Vaira, L. A., Salzano, G., Fois, A. G., Piombino, P., & De Riu, G.
- Venue
- International Forum of Allergy & Rhinology
- Publisher
- Wiley
- Published
- 2020-06-15
- Volume
- 10
- Issue
- 9
- Pages
- 1103-1104
- ISSN
- 2042-6976 (ISSN-L)
- 2042-6984
- OpenAlex
- W3018322638
- Cited by
- 283
- References
- 22
- FWCI
- 19.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Potential pathogenesis of ageusia and anosmia in COVID‐19 patients. https://app.cochat.ai/papers/10.1002/alr.22593
- The paper
- Vaira, L. A., Salzano, G., Fois, A. G., Piombino, P., & De Riu, G. (2020). Potential pathogenesis of ageusia and anosmia in COVID‐19 patients. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.22593
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.